Lastly, the promoters of PDCD1, CXCR4, RGCC, and NR4A3 all showed higher accessibility in T‐ALL cells post‐treatment (Figure 7F; Figure S7). The gene discussed is NR4A3; the disease is acute lymphoblastic leukemia.